Atlas FDA

COBAS HPV TEST, 240 TESTS; COBAS HPV TEST, 960 TESTS

FDA premarket approval P100020/S017 · decided 2016-07-07

Approval details

PMA number
P100020
Supplement
S017
Supplement type
Panel Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
COBAS HPV TEST, 240 TESTS; COBAS HPV TEST, 960 TESTS
Generic name
KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
Applicant
Roche Molecular Systems, Inc.
Date received
2015-12-23
Decision date
2016-07-07
Days to decision
197 days
Decision code
APPR
Product code
MAQ
Advisory committee
Microbiology
Expedited review
No
Location
Pleasanton, CA
Statement
Approval for the cobas® HPV Test. The cobas® HPV Test is a qualitative in vitro test for the detection of Human Papillomavirus in cervical specimens collected by a clinician using an endocervical brush/spatula and placed in the ThinPrep® Pap TestTM PreservCyt® Solution or using a cervical broom and placed in SurePath Preservative Fluid. The test utilizes amplification of target DNA by the Polymerase Chain Reaction (PCR) and nucleic acid hybridization for the detection of 14 high-risk (HR) HPV ty

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
cobas® BV/CV (K260021)Roche Molecular Systems, Inc.2026-07-16
cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systems (K260917)Roche Molecular Systems, Inc.2026-07-08
cobas liat CT/NG/MG nucleic acid test (K253759)Roche Molecular Systems, Inc.2026-05-15
cobas liat CT/NG nucleic acid test (K253756)Roche Molecular Systems, Inc.2026-05-15
cobas liat Bordetella panel nucleic acid test (K243753)Roche Molecular Systems, Inc.2025-11-20
cobas CMV (K252481)Roche Molecular Systems, Inc.2025-11-03
cobas HCV (K252484)Roche Molecular Systems, Inc.2025-11-03
cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems (K243455)Roche Molecular Systems, Inc.2025-07-31